In focus · trending topic

clinicaltrial

50 stories · following the connections

Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA

By Nasdaq OMXApr 23, 2018, 12:15 PM UTC

Abeona Therapeutics Enrolls First Patient in ABO-101 Phase 1/2 Clinical Trial for MPS IIIB

By Nasdaq OMXDec 20, 2017, 1:45 PM UTC

Abeona Announces $13.85M Grant from Leading Sanfilippo Syndrome Foundations for Clinical Development of MPS III Gene Therapies

By Nasdaq OMXOct 16, 2017, 12:26 PM UTC

Abeona Therapeutics Enrolls First Two Patients in Pivotal Expansion of Phase 1/2 Clinical Trial in MPS IIIA

By Nasdaq OMXOct 11, 2017, 12:19 PM UTC

Abeona Announces Top-Line One Year Data from ABO-102 MPS IIIA Trial at ARM’s Cell & Gene Meeting on the Mesa

By Nasdaq OMXOct 6, 2017, 12:25 PM UTC

Abeona Therapeutics Announces Upcoming Conference Participation

By Nasdaq OMXSep 22, 2017, 12:45 PM UTC

Abeona Therapeutics Receives FDA Breakthrough Therapy Designation for EB-101 Autologous Cell Therapy in Epidermolysis Bullosa

By Nasdaq OMXAug 29, 2017, 1:05 PM UTC

Abeona Therapeutics to Host Gene Therapy R&D Day on October 11, 2017

By Nasdaq OMXAug 17, 2017, 1:15 PM UTC